SCHEMBL14764203

SCHEMBL14764203

CCOc1ccc(CC)cc1[O]

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.42
ALDH1A1 P00352 4/20 0.42
HTT P42858 2/20 0.42
POLB P06746 2/20 0.42
LMNA P02545 1/20 0.42
HPGD P15428 1/20 0.42
XBP1 P17861 1/20 0.42
CALM1 P0DP23 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
NPC1 O15118 1/20 0.40
USP2 O75604 1/20 0.40
RAB9A P51151 1/20 0.40
HSD17B10 Q99714 1/20 0.40
NPSR1 Q6W5P4 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
TACR2 P21452 1/20 0.39
TSHR P16473 1/20 0.39
CREBBP Q92793 1/20 0.39
NOS3 P29474 1/20 0.38
NOS1 P29475 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14764674 0.85 CSNK2A1 (0.47) MAPTALDH1A1POLBLMNAHPGD
SCHEMBL14764249 0.84 MAPT (0.42) MAPTALDH1A1HTTPOLBLMNA
SCHEMBL14764223 0.82 CA2 (0.47) ALDH1A1HTTLMNASMN1; SMN2NPSR1
SCHEMBL2521728 0.81 CALM1 (0.51) MAPTALDH1A1HTTPOLBLMNA
SCHEMBL14764237 0.80 RXRA (0.55) MAPTALDH1A1HTTPOLBLMNA
SCHEMBL12797858 0.78 MAPT (0.48) MAPTALDH1A1HTTPOLBLMNA
SCHEMBL10282410 0.78 ESR1 (0.46) MAPTALDH1A1HTTCALM1SMN1; SMN2
SCHEMBL14764344 0.78 MAPT (0.47) MAPTALDH1A1HTTPOLBLMNA
SCHEMBL23271885 0.76 ALDH1A1 (0.41) MAPTALDH1A1POLBLMNAHPGD
SCHEMBL12503974 0.76 CSNK2A1 (0.54) MAPTALDH1A1HTTPOLBLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190085007-A1 4-methylcatechol Derivatives and Uses Thereof Thanares GmbH (DE) 2019-03-21 US claimed
US-20160347782-A1 4-methylcatechol Derivatives and Uses Thereof Thanares GmbH (DE) 2016-12-01 US claimed
WO-2013034119-A1 4-METHYLCATECHOL DERIVATIVES UND USE THEREOF Thanares GmbH (DE) 2013-03-14 WO claimed
US-20190085007-A1 4-methylcatechol Derivatives and Uses Thereof Thanares GmbH (DE) 2019-03-21 US disclosed
US-20160347782-A1 4-methylcatechol Derivatives and Uses Thereof Thanares GmbH (DE) 2016-12-01 US disclosed
WO-2013034119-A1 4-METHYLCATECHOL DERIVATIVES UND USE THEREOF Thanares GmbH (DE) 2013-03-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190085007-A1 4-methylcatechol Derivatives and Uses Thereof ST3GAL3, GALE, DPP4 MAPT 1067/4885ALDH1A1 725/4885HTT 2102/4885
US-20160347782-A1 4-methylcatechol Derivatives and Uses Thereof ST3GAL3, GALE, DPP4 MAPT 1067/4885ALDH1A1 725/4885HTT 2102/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.